Lab
Laboratorio Clinico Obymar
Laboratorio Clinico Obymar was paid $356K by Medicaid between Jan 2018 and Dec 2024, across 41 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 14% of everything it billed.
33Billing provider infoLABORATORIO CLINICO OBYMAR
MOCA, PR 00676
MOCA, PR 00676
33aNPI1760563563assigned 10/18/2006
33bProvider typeClinical Medical Laboratory
28Total paid$356K
24GClaims29,780
24DCodes billed41
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#335 of 777
Median peer was paid$278K
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,065 | $35K | |
| 2019 | 2,283 | $15K | |
| 2020 | 2,644 | $36K | |
| 2021 | 3,374 | $52K | |
| 2022 | 3,889 | $62K | |
| 2023 | 5,468 | $59K | |
| 2024incomplete | 8,057 | $97K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 14% | 3,171 | 2,928 | $49K |
| 80061 | Lipid panel | 12% | 3,419 | 3,160 | $43K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 12% | 1,053 | 920 | $42K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9.5% | 4,649 | 4,208 | $34K |
| 80053 | Comprehensive metabolic panel | 7.9% | 2,852 | 2,600 | $28K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7.6% | 1,219 | 1,039 | $27K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.9% | 610 | 571 | $17K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.3% | 1,647 | 1,523 | $15K |
| 82274 | 4.1% | 960 | 862 | $15K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.6% | 274 | 236 | $13K |
| 81000 | 2.7% | 3,148 | 2,942 | $10K | |
| 83970 | 2.3% | 183 | 180 | $8K |
29 more codes
| 80048 | Basic metabolic panel (calcium, ionized) | 1.6% | 720 | $6K |
| 82607 | 1.2% | 268 | $4K | |
| 82043 | 1.2% | 732 | $4K | |
| 86328 | <1% | 200 | $3K | |
| 84153 | <1% | 190 | $3K | |
| 82746 | <1% | 188 | $3K | |
| 86738 | <1% | 173 | $3K | |
| 87088 | <1% | 322 | $3K | |
| 87276 | <1% | 202 | $2K | |
| 87275 | <1% | 201 | $2K | |
| 84439 | <1% | 232 | $2K | |
| 82570 | <1% | 409 | $2K | |
| 82728 | <1% | 144 | $2K | |
| 81001 | <1% | 680 | $2K | |
| 83550 | <1% | 172 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 260 | $2K |
| 80074 | <1% | 28 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 155 | $1K |
| 83540 | <1% | 174 | $1K | |
| 85651 | <1% | 315 | $1K | |
| 85730 | <1% | 176 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 17 | $872.61 |
| 84479 | <1% | 155 | $828.15 | |
| 85610 | <1% | 176 | $733.75 | |
| 84550 | <1% | 160 | $727.89 | |
| 86701 | <1% | 75 | $511.39 | |
| 82947 | <1% | 41 | $111.34 | |
| 86430 | <1% | 16 | $92.80 | |
| 86592 | <1% | 14 | $60.58 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHERNANDEZ, VANESSA (MEDICAL TECHNOLOGY PORPIETARIA)